Neuropathological diagnostic criteria for Alzheimer's disease

Neuropathology

Volumn 24, Issue 3, 2004, Pages 254-260

  Murayama, Shigeo ^a,b   Saito, Yuko ^a  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^b NONE   (Japan)

Author keywords

Amyloid beta protein; Neurofibrillary tangles; Senile plaques; Tau

Indexed keywords

BIOLOGICAL MARKER; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; AUTOPSY; CEREBROSPINAL FLUID ANALYSIS; COGNITIVE DEFECT; CONFERENCE PAPER; CONSENSUS; DEGENERATIVE DISEASE; DEMENTIA; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; DISEASE SEVERITY; EVALUATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; NEUROFIBRILLARY TANGLE; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGANIZATION; OUTCOMES RESEARCH; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROBABILITY; SENILE PLAQUE; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; SENSITIVITY AND SPECIFICITY;

EID: 4644298126     PISSN: 09196544     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2004.00571.x     Document Type: Conference Paper

References (13)

1. Alzheimer A. Ueber eine eigenartige Krankheitsfaelle des spaeteren Alters. Z Gesamte Neurol Psychiatr 1911; 4: 356-385.
2. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 1991; 82: 239-259.
3. Mirra SS, Heyman A, McKeel D et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479-486.
4. Gomez-Isla T, Hollister R, West H et al. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol 1997; 41: 17-24.
5. The National Institute on Aging and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging 1997; 18: S1-S2.
6. McKeith IG, Galasko D, Kosaka K et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996; 47: 1113-1124.
7. Yamaguchi H, Haga C, Hirai S, Nakazato Y, Kosaka K. Distinctive, rapid, and easy labeling of diffuse plaques in the Alzheimer brains by a new methenamine silver stain. Acta Neuropathol (Berl) 1990; 79: 569-572.
8. Saito Y, Kawashima A, Ruberu NN et al. Accumulation of phosphorylated alpha-synuclein in aging human brain. J Neuropathol Exp Neurol 2003; 62: 644-654.
9. Saito Y, Nakahara K, Yamanouchi H, Murayama S. Severe involvement of ambient gyrus in dementia with grains. J Neuropathol Exp Neurol 2002; 61: 789-796.
10. Roman GC, Tatemichi TK, Erkinjuntti T et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43: 250-260.
11. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140: 566-572.
12. Breteler MM, van den Ouweland FA, Grobbee DE, Hofman A. A community-based study of dementia: the Rotterdam Elderly Study. Neuroepidemiology 1992; 11: 23-28.
13. Blennow K, Vanmechelen E. CSF markers for pathogenic processes in Alzheimer's disease: diagnostic implications and use in clinical neurochemistry. Brain Res Bull 2003; 61: 235-242.